Sun Pharmaceutical Industries Ltd. — Earnings Release 2022

Jul 16, 2021

Sun Pharmaceutical Industries Limited SUN HOUSE, CTS No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 CIN: L24230GJ1993PLC019050 www.sunpharma.com

==> picture [65 x 88] intentionally omitted <==

July 16, 2021

National Stock Exchange of India Limited, BSE Limited, Exchange Plaza, 5th Floor, Market Operations Dept. Plot No. C/1, G Block, P. J. Towers, Bandra Kurla Complex, Dalal Street, Bandra (East), Mumbai- 400 051 Mumbai - 400 001 Scrip Symbol: SUNPHARMA Scrip Code: 524715

Sub: Press Release

Dear Sir / Madam,

We are pleased to enclose herewith our Press Release relating to Earnings Call for financial results for the first quarter ending June 30, 2021, which we shall be releasing after sending this letter to you.

This is for your information and dissemination.

Thanking you,

Yours faithfully,

For Sun Pharmaceutical Industries Limited

Ashok Digitally signed by Ashok Indulal Indulal Bhuta Date: 2021.07.16 Bhuta 16:37:32 +05'30'

Ashok I. Bhuta Compliance Officer Enclosed: As above

Registered Office : SPARC, Tandalja, Vadodara – 390 012 India. Reaching People. Touching Lives

Sun Pharmaceutical Industries Limited SUN HOUSE, CTS No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 CIN: L24230GJ1993PLC019050 www.sunpharma.com

==> picture [65 x 89] intentionally omitted <==

FOR IMMEDIATE RELEASE

Sun Pharma to announce first quarter results on July 30, 2021

July 16, 2021, Mumbai: Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) will announce results for the first quarter ending June 30, 2021 on July 30, 2021. These results will also be available on the Company website, www.sunpharma.com.

Earnings call (06.30 pm IST, July 30, 2021)

The Company will conduct an hour long call at 06.30 pm IST on July 30, 2021 where senior management will discuss the Company’s performance and answer questions from participants. To participate in this conference call, please pre-register yourself on below link and dial the numbers provided below, five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.sunpharma.com. A transcript of this conference call will also be available on the website.

Summary of events

Event	Date and time	Telephone number/ website
Earnings release	July 30, 2021	www.sunpharma.com
Earnings conference call	06.30 pm IST, July 30, 2021	Universal Number: +91 22 5064 1325 Via audio webcast, details of which will be made available on www.sunpharma.com
Pre‐registration details (to avoid wait time)		Click here for DiamondPassRegistration
Replay of conference call	July 30, 2021 to August 06, 2021	India: +91 22 7194 5757 India: +91 22 6663 5757 Code: 93696 Via audio webcast playback, details of which will be made available on www.sunpharma.com

Registered Office : SPARC, Tandalja, Vadodara – 390 012. India Reaching People. Touching Lives

Sun Pharmaceutical Industries Limited SUN HOUSE, CTS No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 CIN: L24230GJ1993PLC019050 www.sunpharma.com

==> picture [65 x 89] intentionally omitted <==

Disclaimer:

Statements in this “Document” describing the Company’s objectives, projections, estimates, expectations, plans or predictions or industry conditions or events may be “forward looking statements” within the meaning of applicable securities laws and regulations. Actual results, performance or achievements could differ materially from those expressed or implied. The Company undertakes no obligation to update or revise forward looking statements to reflect developments or circumstances that arise or to reflect the occurrence of unanticipated developments/circumstances after the date hereof.

- About Sun Pharmaceutical Industries Limited (CIN L24230GJ1993PLC019050):

Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in over 100 countries across the world, at affordable prices. Its global presence is supported by manufacturing facilities spread across 6 continents and approved by multiple regulatory agencies, coupled with a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities across multiple R&D centers, with investments of approximately 6-7% of annual revenues in R&D. For further information, please visit www.sunpharma.com & follow us on Twitter @SunPharma_Live

Contacts:

Investors: Media: Nimish Desai Gaurav Chugh Tel +91 22 4324 4324, Xtn 2778 Tel Tel Direct +91 22 4324 2778 Tel Direct Mobile +91-98203 30182 Mobile E mail nimish.desai@sunpharma.com E mail	+91 22 4324 4324, Xtn 5373 +91 22 4324 5373 +91 98104 71414 Gaurav.chugh@sunpharma.com

Registered Office : SPARC, Tandalja, Vadodara – 390 012. India Reaching People. Touching Lives